The Disinfectant Effect of Modified Hydrothermal Nanotitania Extract on Candida albicans
Open Access
- 5 February 2021
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2021, 1-5
- https://doi.org/10.1155/2021/6617645
Abstract
Candida albicans is a pathogenic yeast typically associated with diseases such as HIV, AIDS, and other immunocompromised conditions. It is rarely the cause of fatalities and is commonly treated with drugs administered orally or intravenously. In this experiment, Candida albicans was tested with an extract of modified hydrothermal nanotitania to identify whether the material is capable of inhibiting the organisms growth. The extract was mixed with the Candida albicans in a culture media preparation to determine whether the organisms were able to grow. The test showed that modified hydrothermal nanotitania inhibits the growth of this organism.This publication has 27 references indexed in Scilit:
- Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticlesNanomedicine: Nanotechnology, Biology and Medicine, 2010
- Adhesion of Candida albicans to various dental implant surfaces and the influence of salivary pellicle proteinsActa Biomaterialia, 2010
- Antifungal susceptibility of Candida albicans biofilms on titanium discs with different surface roughnessClinical Oral Investigations, 2007
- Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane SterolsInfection and Immunity, 2003
- Comparison of Caspofungin and Amphotericin B for Invasive CandidiasisThe New England Journal of Medicine, 2002
- Biofilm Formation by the Fungal Pathogen Candida albicans : Development, Architecture, and Drug ResistanceJournal of Bacteriology, 2001
- Evolution of Drug Resistance in Experimental Populations of Candida albicansJournal of Bacteriology, 2000
- Pneumocystis cariniiPneumonia and Mucosal Candidiasis in Previously Healthy Homosexual MenThe New England Journal of Medicine, 1981
- Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.The Journal of Antibiotics, 1975
- Growth of Candida albicans in Saliva: Stimulation by Glucose Associated with Antibiotics, Corticosteroids, and Diabetes MellitusThe Journal of Infectious Diseases, 1971